Drug regulators order Sun Pharma to halt eye-drop production at Assam plant

Drug regulators ordered Sun Pharma to halt eye-drop production at its Assam plant following a recall of ophthalmic products, according to a report.

Detected & updated continuously · Source: Nebula

Story subjects

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula